Skip to main content

Topical Antibacterial Agents

  • Chapter
Wound Healing and Ulcers of the Skin
  • 2158 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Damour O, Hua SZ, Lasne F, et al: Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 1992; 18:479–485

    Article  PubMed  Google Scholar 

  2. Gasset AR, Ishii Y: Cytotoxicity of chlorhexidine. Can J Ophthalmol 1975; 10:98–100

    PubMed  Google Scholar 

  3. Faddis D, Daniel D, Boyer J: Tissue toxicity of antiseptic solutions. A study of rabbit articular and periarticular tissues. J Trauma 1977; 17:895–897

    PubMed  Google Scholar 

  4. Kimbrough RD: Review of the toxicity of hexachlorophene. Arch Environ Health 1971; 23:119–122

    PubMed  Google Scholar 

  5. Eaglstein WH, Falanga V: Chronic wounds. Surg Clin North Am 1997; 77:689–700

    PubMed  Google Scholar 

  6. Murray PR, Rosenthal KS, Kobayashi GS, et al: Sterilization, disinfection, and antisepsis. In: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA (eds) Medical Microbiology, 3rd edn. St. Louis: Mosby. 1988; pp 74–78

    Google Scholar 

  7. Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1116–1117

    Google Scholar 

  8. Lineaweaver W, McMorris S, Soucy D, et al: Cellular and bacterial Toxicities of topical antimicrobials. Plast Reconstr Surg 1985; 75:394–396

    PubMed  Google Scholar 

  9. O'Toole EA, Goel M, Woodley DT: Hydrogen peroxide inhibits human keratinocyte migration. Dermatol Surg 1996; 22:525–529

    Article  PubMed  Google Scholar 

  10. Tur E, Bolton L, Constantine BE: Topical hydrogen peroxide treatment of ischemic ulcers in the guinea pig: blood recruitment in multiple skin sites. J Am Acad Dermatol 1995; 33:217–221

    Article  PubMed  Google Scholar 

  11. Christensen OB, Anehus S: Hydrogen peroxide cream: an alternative to topical antibiotics in the treatment of impetigo contagiosa. Acta Derm Venereol (Stockh) 1994; 74:460–462

    Google Scholar 

  12. Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pg 1123

    Google Scholar 

  13. Southwood T, Lamb CM, Freeman J: Ingestion of potassium permanganate crystals by a three-year-old boy. Med J Aust 1987; 146:639–640

    PubMed  Google Scholar 

  14. Middleton SJ, Jacyna M, McClaren D, et al: Haemorrhagic pancreatitis — a cause of death in severe potassium permanganate poisoning. Postgrad Med J 1990; 66:657–658

    PubMed  Google Scholar 

  15. Rutala WA: Antisepsis, disinfection, and sterilization in hospitals and related institutions. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds) Manual of Clinic Microbiology, 6th edn. Washington: ASM Press. 1995; pp 227–245

    Google Scholar 

  16. Disinfectants and preservatives. In: Kathleen Parfitt (ed): Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1123–1124

    Google Scholar 

  17. Georgiade NG, Harris WA: Open and closed treatment of burns with povidone iodine. Plast Reconstr Surg 1973; 52:640–644

    PubMed  Google Scholar 

  18. Burks RI: Povidone-iodine solution in wound treatment. Phys Ther 1998; 78:212–218

    PubMed  Google Scholar 

  19. Smoot EC 3rd, Kucan JO, Roth A, et al: In vitro toxicity testing for antibacterials against human keratinocytes. Plast Reconstr Surg 1991; 87:917–924

    PubMed  Google Scholar 

  20. Cooper ML, Laxer JA, Hansbrough JF: The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma 1991; 31:775–784

    PubMed  Google Scholar 

  21. Kozuka T: Patch testing to exclude allergic contact dermatitis caused by povidone-iodine. Dermatology 2002; 204:96–98

    Article  PubMed  Google Scholar 

  22. Nishioka K, Seguchi T, Yasuno H, et al: The results of ingredient patch testing in contact dermatitis elicited by povidone-iodine preparations. Contact Dermatitis 2000; 42:90–94

    Article  PubMed  Google Scholar 

  23. Erdmann S, Hertl M, Merk HF: Allergic contact dermatitis from povidone-iodine. Contact Dermatitis 1999; 40:331–332

    Google Scholar 

  24. Niedner R: Cytotoxicity and sensitization of povidone-iodine and other frequently used unti-infective agents. Dermatology 1997; 195:89–92

    Google Scholar 

  25. Lopez Saez MP, de Barrio M, Zubeldia JM, et al: Acute lgE-mediated generalized urticaria-angioedema after application of povidone-iodine. Allergol Immunopathol (Madr) 1998; 26 23–26

    Google Scholar 

  26. Waran KD, Munsick RA: Anaphylaxis from povidone-iodine. Lancet 1995; 345:1506

    Article  Google Scholar 

  27. Pierard-Franchimont C, Paquet P, Arrese JE, et al: Healing rate and bacterial necrotizing vasculitis in venous leg ulcers. Dermatology 1997; 194:383–387

    PubMed  Google Scholar 

  28. Fumal I, Braham C, Paquet P, et al: The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof of concept study. Dermatology 2002; 204:70–74

    Article  PubMed  Google Scholar 

  29. O'Meara SM, Cullum NA, Majid M, Sheldon TA: Systemic review of antimicrobial agents used for chronic wounds. Br J Surg 2001; 88:4–21

    Article  PubMed  Google Scholar 

  30. Donohue K, Rausch H, Falanga V: Wound bed preparation. In: Rovee DT, Maibach HI (eds) The Epidermis in Wound Healing. Boca Raton, CRC Press. 2004; pp 255–264.

    Google Scholar 

  31. Kirsner RS, Martin LK, Drosou A: Wound microbiology and the use of antibacterial agents. In: Rovee DT, Maibach HI (eds) The Epidermis in Wound Healing. Boca Raton: CRC Press. 2004; pp 155–182.

    Google Scholar 

  32. Dychdala GR: Chlorine and chlorine compounds. In: Block SS (ed) Disinfection, Sterilization and Preservation. 4th edn. Philadelphia: Lea & Febiger. 1991; pp 131–151

    Google Scholar 

  33. Leaper DJ: Eusol: Still awaiting proper clinical trials. Br Med J 1992; 304:930–931

    Google Scholar 

  34. Mertz PM, Alvarez OM, Smerbeck RV, et al: A new in vivo model for the evaluation of topical antiseptics on superficial wounds. Arch Dermatol 1984; 120:58–62

    Article  PubMed  Google Scholar 

  35. Brennan SS, Foster ME, Leaper DJ: Antiseptic toxicity in wound healing by secondary intention. J Hosp Infect 1986; 8:263–267

    Article  PubMed  Google Scholar 

  36. Brennan SS, Leaper DJ: The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. Br J Surg 1985; 72:780–782

    PubMed  Google Scholar 

  37. Spadaro JA, Chase SE, Webster DA: Bacterial inhibition by electrical activation of percutaneous silver implants. J Biomed Mater Res 1986; 20:565–577

    Article  PubMed  Google Scholar 

  38. Lansdown AB: Silver I. Its antibacterial properties and mechanism of action. J Wound Care 2002; 11:125–130

    PubMed  Google Scholar 

  39. Deitch EA, Marino AA, Gillespie TE, et al: Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother 1983; 23:356–359

    PubMed  Google Scholar 

  40. Colmano G, Edwards SS, Barranco SD: Activation of antibacterial silver coatings on surgical implants by direct current: preliminary studies in rabbits. Am J Vet Res 1980; 41:964–966

    PubMed  Google Scholar 

  41. Tsai WC, Chu CC, Chiu SS, et al: In vitro quantitative study of newly made antibacterial braided nylon sutures. Surg Gynecol Obstet 1987; 165:207–211

    PubMed  Google Scholar 

  42. Chu CC, Tsai WC, Yao JY, et al: Newly made antibacterial braided nylon sutures. I. In vitro qualitative and in vivo preliminary biocompatibility study. J Biomed Mater Res 1987; 21:1281–1300

    Article  PubMed  Google Scholar 

  43. Wysor MS, Zollinhofer RE: On the mode of action of silver sulphadiazine. Pathol Microbiol 1972; 38:296–308

    Google Scholar 

  44. Modak SM, Fox CL Jr: Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 1973; 22:2391–2404

    Article  PubMed  Google Scholar 

  45. Lowbury EJ, Babb JR, Bridges K, et al: Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant. Gram-negative bacilli. Br Med J 1976; 1:493–496

    PubMed  Google Scholar 

  46. Fuller FW, Parrish M, Nance FC: A review of the dosimetry of 1% silver sulphadiazine cream in burn wound treatment. J Burn Care Rehabil 1994; 15:213–223

    PubMed  Google Scholar 

  47. Wlodkowski TJ, Rosenkranz HS: Antifungal activity of silver sulphadiazine. Lancet 1973; 2:739–740

    Article  Google Scholar 

  48. Wright JB, Lam K, Hansen D, et al: Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999; 27:344–350

    PubMed  Google Scholar 

  49. Hidalgo E, Dominguez C: Study of cytotoxicity mechanisms of silver nitrate in human dermal fibroplasts. Toxicol Lett 1998; 98:169–179

    Article  PubMed  Google Scholar 

  50. Hidalgo E, Bartolome R, Barroso C, et al: Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998; 11:140–151

    Article  PubMed  Google Scholar 

  51. McCauley RL, Li YY, Poole B, et al: Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res 1992; 52:276–285

    Article  PubMed  Google Scholar 

  52. Antibacterials. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference. 32nd edn. London: Pharmaceutical Press. 1999; pp 247, 248

    Google Scholar 

  53. Monafo WW, Freedman B: Topical therapy for burns. Surg Clin North Am 1987; 67:133–145

    PubMed  Google Scholar 

  54. Pirnay JP, De Vos D, Cochez C, et al: Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41:1192–1202

    Article  PubMed  Google Scholar 

  55. Yoshida T, Ohura T, Sugihara T, et al: Clinical efficacy of silver sulfadiazine (AgSD: Geben cream) for ulcerative skin lesions infected with MRSA. Jpn J Antibiot 1997; 50:39–44

    PubMed  Google Scholar 

  56. Marone P, Monzillo V, Perversi L, et al: Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria. J Chemother 1998; 10:17–21

    PubMed  Google Scholar 

  57. Degreef H, Dooms-Goossens A: Patch testing with silver sulfadiazine cream. Contact dermatitis 1985; 12:33–37

    PubMed  Google Scholar 

  58. McKenna SR, Latenser BA, Jones LM, et al: Serious silver sulphadiazine and mafenide acetate dermatitis. Burns 1995; 21:310–312

    Article  PubMed  Google Scholar 

  59. Fuller FW, Engler PE: Leukopenia in non-septic burn patients receiving topical 1% silver sulfadiazine cream therapy: a survey. J Burn Care Rehabil 1988; 9:606–609

    PubMed  Google Scholar 

  60. Thomson PD, Moore NP, Rice TL, et al: Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent. J Burn Care Rehabil 1989; 10:418–420

    PubMed  Google Scholar 

  61. Chou TD, Gibran NS, Urdahl K, et al: Methemoglobinemia secondary to topical silver nitrate therapy — a case report. Burns 1999; 25:549–552

    Article  PubMed  Google Scholar 

  62. Geronemus RG, Mertz PM, Eaglstein WH: Wound healing. The effects of topical antimicrobial agents. Arch Dermatol 1979; 115:1311–1314

    Article  PubMed  Google Scholar 

  63. Glesinger R, Cohen AD, Bogdanov-Berezovsky A, et al: A randomized controlled trial of silver sulfadiazine, biafine, and saline-soaked gauze in the treatment of superficial partial-thickness burn wounds in pigs. Acad Emerg Med 2004; 11:339–342

    Article  PubMed  Google Scholar 

  64. Watcher MA, Wheeland RG: The role of topical agents in the healing of full thickness wounds. J Dermatol Surg Oncol 1989; 15:1188–1195

    PubMed  Google Scholar 

  65. Phillips TJ, Dover JS: Leg ulcers. J Am Acad Dermatol 1991; 25:965–987

    PubMed  Google Scholar 

  66. Blair SD, Backhouse CM, Wright DDI, et al: Do dressings influence the healing of chronic venous ulcers? Phlebology 1988; 3:129–134

    Google Scholar 

  67. Bishop JB, Phillips LG, Mustoe TA, et al: A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 1992; 16:251–257

    Article  PubMed  Google Scholar 

  68. Van Den Hoogenband HM: Treatment of leg ulcers with split-thickness skin grafts. J Dermatol Surg Oncol 1984; 10:605–608

    PubMed  Google Scholar 

  69. Niedner R, Schopf E: Wound infections and antibacterial therapy. In: Westerhof W (ed) Leg Ulcers: Diagnosis and Treatment. Amsterdam: Elsevier. 1993; pp 293–303

    Google Scholar 

  70. Saji M, Taguchi S, Uchiyama K, et al: Efficacy of gentian violet in the eradication of methicillin-resistant Staphylococcus aureus from skin lesions. J Hosp Infect 1995; 31:225–228

    Article  PubMed  Google Scholar 

  71. Niedner R, Schopf E: Inhibition of wound healing by antiseptics. Br J Dermatol 1986; 115[Suppl]:41–44

    PubMed  Google Scholar 

  72. Mobacken H: Gentian violet and wound repair. J Am Acad Dermatol 1986; 15:1303

    Google Scholar 

  73. Bjornberg A, Mobacken H: Necrotic skin reactions caused by 1% gentian violet and brilliant green. Acta Derm Vevereol 1972; 52:55–60

    Google Scholar 

  74. Mobacken H, Zederfeldt B: Influence of a cationic triphenylmethane dye on granulation tissue growth in vivo. An experimental study in rats. Acta Derm Venereol 1973; 53:167–172

    PubMed  Google Scholar 

  75. Balabanova M, Popova L, Tchipeva R: Dyes in dermatology. Clin Dermatol 2003; 21:2–6

    Article  PubMed  Google Scholar 

  76. Disinfectants and preservatives. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1111–1112

    Google Scholar 

  77. Goldwyn RM: Carl August Burow. Plast Reconstr Surg 1984; 73:687–690

    PubMed  Google Scholar 

  78. Wilkinson JD: Formulary of topical applications. In: Champion RH, Burton JL, Ebling FJC (eds) Rook/Wilkinson/Ebling Textbook of Dermatology. 5th edn. Oxford: Blackwell Scientific Publications. 1992; pp 3122

    Google Scholar 

  79. Supplementary drugs and other substances. In: Kathleen Parfitt (ed) Martindale — The Complete Drug Reference, 32nd edn. London: Pharmaceutical Press. 1999; pp 1547

    Google Scholar 

  80. Thorp MA, Kruger J, Oliver S, et al: The antibacterial activity of acetic acid and Burow's solution as topical otologic preparations. J Laryngol Otol 1998; 112:925–928

    PubMed  Google Scholar 

  81. Stern JC, Shah MK, Lucente FE: In vitro effectiveness of 13 agants in otomycosis and review of the literature. Laryngoscope 1988; 98:1173–1177

    PubMed  Google Scholar 

  82. Clayton MI, Osborne JE, Rutherford D, et al: A double-blind, randomized, prospective trial of a topical antiseptic versus a topical antibiotic in the treatment of otorrhoea. Clin Otolaryngol 1990; 15:7–10

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). Topical Antibacterial Agents. In: Wound Healing and Ulcers of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26761-1_11

Download citation

  • DOI: https://doi.org/10.1007/3-540-26761-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21275-1

  • Online ISBN: 978-3-540-26761-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics